Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) shares are down during early trading on Friday following the company’s recent financial update, which revealed a net loss for the fourth quarter.
The company reported a net loss of 73 cents per diluted share, for the fourth quarter of 2025, beating the Street view of $1.65 loss.
Acurx ended the quarter with cash totaling $7.6 million, an increase from $3.7 million a year earlier, and raised approximately $1.5 million through its Equity Line of Credit during the fourth quarter.
The company is focused on developing a new …